Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Gritgen Therapeutics Co., Ltd.

Clinical trials sponsored by Gritgen Therapeutics Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

One-Time gene shot aims to stop bleeding in hemophilia a Results expected Nov 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

One-Shot gene therapy aims to fix bleeding disorder

Disease control Ongoing

This early-stage trial is testing a single-dose gene therapy called GS1191-0445 in 7 Chinese adults with severe hemophilia A. The therapy uses a harmless virus to deliver a working gene to the liver, so the body can produce its own clotting factor. The main goal is to check safet…

Phase 1/2 • Sponsor: Gritgen Therapeutics Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 12:29 UTC